Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cotrimoxazole versus benzathine penicillin for impetigo in children
ACTRN12607000592448Phase 2Completed
- Sponsor
- Menzies School of Health Research
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of trimethoprim + sulfamethoxazole and Benzathine penicillin in impetigo (2 arms), sponsored by Menzies School of Health Research. Primary endpoint: Successful treatment of skin sores. Started Jan 2008; status: completed.
02
Drugs
trimethoprim + sulfamethoxazoleBenzathine penicillin
03
Conditions
impetigo
Beyond the preview
Go deeper on ACTRN12607000592448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000592448.